Evidence map›Paper›PMID 40559193›Full record

ArticleInfectious disease reports2025

Anna Anselmo, Fabiana Rizzo, Elena Gervasi, Luca Corrent, Andrea Ciammaruconi, Silvia Fillo, Antonella Fortunato, Anna Maria Marella, Silvia Costantini, Luca Baldassari and 2 more

Abstract readCase Reports
In one paragraph

Article in Infectious disease reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Molecular frequency ofNew microbes and new infections · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anna AnselmoDefense Institute for Biomedical Sciences, 00184 Rome, Italy.ORCID 0009-0004-7880-2828
Fabiana RizzoDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0001-9748-4571
Elena GervasiInfectious Diseases Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0009-0003-6491-0345
Luca CorrentDefense Institute for Biomedical Sciences, 00184 Rome, Italy.
Andrea CiammaruconiDefense Institute for Biomedical Sciences, 00184 Rome, Italy.
Silvia FilloDefense Institute for Biomedical Sciences, 00184 Rome, Italy.ORCID 0000-0001-5100-2573
Antonella FortunatoDefense Institute for Biomedical Sciences, 00184 Rome, Italy.
Anna Maria MarellaDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.
Silvia CostantiniDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0009-0005-5191-7489
Luca BaldassariSchool of Medicine, University of Milano-Bicocca, 20126 Milan, Italy.
Florigio ListaDefense Institute for Biomedical Sciences, 00184 Rome, Italy.
Alessandra CiervoDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0002-0664-9375

Funding

Italian General Secretariat of Defense and the National Armaments Directorate within the "Eu-ropean Biodefence Laboratory Network 2 (EBLN2) project", B1519 ESM4 GP
6 · The paper itself

Abstract

backgroundWhipple's disease (WD) is a rare infection caused by CASE DESCRIPTION: We present the case of a 66-year-old immunocompetent patient with WD and a history of

conclusionThe metagenomic analyses showed the eradication of the two pathogens and a progressive restoration to a healthy/balanced status after antibiotic therapy.

Indexed as

bioinformaticsgut microbiomemetagenomic analysesnext-generation sequencing (NGS)Whipple’s disease (WD)

Identifiers

PMID40559193
PMCPMC12192650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.